|12:00-12:30||Opening in the foyer of BioPartner1|
Quantified Air SysBioSim Pluriomics
|Fundamentals track||Life science track||Life science track|
|14:15-15:15||Leiden Probe Microscopy B.V.||Dr. Reddy’s||Genomescan|
|15:45-16:45||Airbus Defence & Space||Charles River||Biotech Training Facility|
|17:00-18:30||Networking drinks in the foyer of Biopartner1|
Click on a company to visit their website.
Biotech Training Facility (BTF) is a unique training center where people are trained in a real-life pharmaceutical production facility. Good Manufacturing Practices, production operations, process and analytical validations are examples of training topics. The courses contain hands-on training and are key for among others production operators, quality assurance officers, lab technician and maintenance engineers. The facility is also being used as a pilot plant for testing equipment and training on company specific production processes and analytical methods. BTF is completely equipped with cleanrooms, laboratories and a technical area with easily accessible utilities.
IPDO Leiden is the Dutch R&D center of Dr.Reddy’s Laboratories. We develop generic versions of complex injectables from scratch. Our company track record consists of the development of many complex injectables, ranging from liposomes and microspheres to gene delivery. This skill set was a major driver in the acquisition of OctoPlus by Dr. Reddy’s in 2013. Before we became part of Dr.Reddy’s, we were developing new drug products for third parties in a fee for service model. Many of the products we have developed contained a biotech molecule as active ingredient. The development of generic complex injectables is more difficult than you would think at first sight. In our three years of working on these products, having the perfect example in hand, being the innovator product, is helpful but it also means that we have a regulatory obligation to copy it almost perfectly, without actually knowing how it was manufactured. This asks a lot of creativity and agility of our project teams. We do this with about 100 people, all of them are involved in finding out what the innovator product looks like, how could it have been made by reverse engineering, and how we can assure that a bioequivalence study will succeed. We have five teams that each work on multiple projects, supported by expert groups. We work in close collaboration with the R&D lab in India, the manufacturing plants and the R&D center in Cambridge, UK. Our goal is to successfully develop generic complex injectable products, so that expensive drugs become more accessible to those who need it and cannot afford the innovator product. Because Good Health Can’t Wait.
Quantified Air is a Delft University of Technology spin-off developing inexpensive gas sensors that create a fingerprint of air. Applications of our sensors include environmental monitoring, climate control, and personal health. The sensor comprises an array or miniaturized tuning forks, each of which is made sensitive to a specific chemical component. By measuring the detuning of each tuning fork, information is gathered on the concentration of the corresponding chemical. Our devices are inexpensive, low-power, and easy to integrate. This makes them attractive in distributed applications such as networks that provide information on climate uniformity in buildings and production facilities.
Pluriomics is an emerging biotechnology company that delivers innovative human iPSC-derived cell-based models for use in drug discovery & development. Based on our novel proprietary technologies we develop highly functional cell types, such as our hiPSC-derived cardiomyocytes (Pluricyte® Cardiomyocytes). We use these cells in combination with phenotypic assays to deliver high quality assay platforms for pharmaceutical research. Our ambition is to implement our Pluricyte® Cardiomyocyte-based technology platform at various stages of drug discovery to improve preclinical safety and efficacy research, and to provide an alternative for animal testing. Pluriomics has a commercial team and R&D team in Leiden, The Netherlands, and production facilities in Gosselies, Belgium.